1840PPreclinical evaluation of a non-depleting, first-in-class humanized IgG4 agonist anti-ICOS antibody. (23rd October 2018) - Brett, S; Yadavilli, S; Seestaller-Wehr, L; Bhattacharya, S; Jackson, H; Bi, M; Willoughby, J; Zhang, T; Liu, Y-B; Katlinskaya, Y K; Shi, H; Jing, J; et al.